Advanced Therapies Integrates 2021
- Organiser: Life Science Integrates (LSI)
- Name: Life Science Integrates (LSI)
- Email: firstname.lastname@example.org
Announcing the inaugural Advanced Therapies Integrates event - enabling strategic debate and collaboration across the Advanced Therapies and Medicinal Products (ATMP) Industry
London, UK, 1st October 2021 / Sciad Newswire / Life Science Integrates (LSI) is delighted to announce the inaugural Advanced Therapies Integrates event on 7th October 2021, hosted live online in partnership with The Cell and Gene Therapy Catapult.
The past years have seen an intense global focus on healthcare like never before. Life Science Integrates aims to facilitate the translation of cutting-edge research and innovation into the widespread adoption of Advanced Therapies to improve patient outcomes and revolutionize healthcare economics.
This event will constitute a new forum, bringing together industry leaders to deliver the full potential of ATMPs. Pharmaceutical innovations are taking place at an astonishing pace. Advances in areas such as genomics have seen the emergence of highly effective but complex therapeutics, including cell and gene therapies, regenerative medicines and tissue therapies.
While these innovations offer transformative potential to healthcare globally, strategic challenges remain surrounding the development, deployment and utilisation of these ground-breaking medical technologies.
Focusing on three core themes of Trending Technology, Novel Networks & Finance, and Produce and Use, the event addresses key questions for the development of the industry such as:
- How good are we at making Advanced Therapies today? What should the future look like?
- How can we expand the development and use of autologous ATMPs?
- Are we doing enough to put investments and infrastructure in place to rapidly translate ATMPs from concept to clinic?
With over 70 expert speakers, the event will uniquely engage across the widest possible network from pharma innovators, regulators, equipment & technology providers, academia, industry associations, and governing bodies.
LSI are delighted to announce that the content-packed agenda will be initiated with opening remarks from Dr Sharon Brownlow, Chief Business Officer at the Cell and Gene Therapy Catapult. The Cell and Gene Therapy Catapult bridges the gap between research and full-scale commercialisation to ensure a thriving UK industry can deliver life-changing advanced therapies to the world. With an academic background in biophysics and postdoctoral research, followed by 30 years’ experience in biotechnology, Sharon’s contribution to the event is not to be missed. “I am looking forward to the opportunity offered by Advanced Therapies Integrates to come together with experts from across the industry to address key topics across manufacturing, regulatory, supply chain and more, that will enable the UK to continue to build a strong advanced therapies ecosystem and continue to forge powerful collaborations,” stated Sharon.
“Coming together to share our industry insights facilitates many additional conversations that will no doubt lead to new and exciting collaborations over the coming months and years,” commented LSI Co-Founder and Executive Director, Samuel Thangiah. “The team at Life Science Integrates sincerely thank all this year’s speakers, sponsors and partners for contributing towards what promises to be such a rich and varied conference.”
View the full agenda and register now for the very first Advanced Therapies Integrates event.